Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Waldemar Link GmbH & Co. KG
- Trial code
- NCT04688593
- Record updated
- 25 January 2024
- Original description
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.Read full original descriptionShow less
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.
The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Inclusion: Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link; Age ≥ 18 years; Fully signed patient informed cons.
Exclusion: Revisions; Body Mass Index (BMI) ≥ 40 kg/m²; Patient who is foreseeable not able to understand the study and the study-related circumstances; Patients who is foreseeable non-compliant to the treatment and the follow-ups; Pregnant or breast-feeding women; Prisoner.